Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines. Here's what investors need to know about this small-cap biotech company. Iovance ...

Layoffs leave more than empty desks—they leave uncertainty, guilt and anxiety. Three simple steps will help you regain ...

Momentum Bioscience is working on technology to diagnose sepsis faster (Image: Jacqueline Cross) Sumi Thaker, Momentum Bioscience's CEO, believes the current delay in diagnosis and targeted treatment ...

In 2020, assistant professor Sonia Dahiya built a thriving mushroom farming business, ‘Doctor Dahiya Mushroom Farm’.

A new part of an ocean plant cell has been discovered that might revolutionize farming one day. The structure can take ...

A major biotech breakthrough is happening in New Orleans. Beken Bio, a biotech startup company that is soon to be based at ...

New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...

Sara Imhof, Ph.D., vice president of the focused initiatives team at the North Carolina Biotechnology Center, has been ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

Press Release 4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will receive USD 400 million upfront, with the potential ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

Contributor Content In his years as Director of Surgical Neuro-Oncology at the University of Southern California (USC), Dr. Thomas Chen has witnessed countless innovations in the world of cancer ...